Literature DB >> 16093497

The murine cardiac 26S proteasome: an organelle awaiting exploration.

Aldrin V Gomes1, Chenggong Zong, Ricky D Edmondson, Beniam T Berhane, Guang-Wu Wang, Steven Le, Glen Young, Jun Zhang, Thomas M Vondriska, Julian P Whitelegge, Richard C Jones, Irving G Joshua, Sheeno Thyparambil, Dawn Pantaleon, Joe Qiao, Joseph Loo, Peipei Ping.   

Abstract

Multiprotein complexes have been increasingly recognized as essential functional units for a variety of cellular processes, including the protein degradation system. Selective degradation of proteins in eukaryotes is primarily conducted by the ubiquitin proteasome system. The current knowledge base, pertaining to the proteasome complexes in mammalian cells, relies largely upon information gained in the yeast system, where the 26S proteasome is hypothesized to contain a 20S multiprotein core complex and one or two 19S regulatory complexes. To date, the molecular structure of the proteasome system, the proteomic composition of the entire 26S multiprotein complexes, and the specific designated function of individual components within this essential protein degradation system in the heart remain virtually unknown. A functional proteomic approach, employing multidimensional chromatography purification combined with liquid chromatography tandem mass spectrometry and protein chemistry, was utilized to explore the murine cardiac 26S proteasome system. This article presents an overview on the subject of protein degradation in mammalian cells. In addition, this review shares the limited information that has been garnered thus far pertaining to the molecular composition, function, and regulation of this important organelle in the cardiac cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16093497     DOI: 10.1196/annals.1341.018

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Proteome dynamics and proteome function of cardiac 19S proteasomes.

Authors:  Ding Wang; Chenggong Zong; Myong-chul Koag; Yueju Wang; Oliver Drews; Caiyun Fang; Sarah B Scruggs; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2011-02-25       Impact factor: 5.911

Review 3.  The role of the proteasome in heart disease.

Authors:  Yi-Fan Li; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2010-09-15

Review 4.  Role of ubiquitin-proteasome system (UPS) in left ventricular hypertrophy (LVH).

Authors:  Federico Cacciapuoti
Journal:  Am J Cardiovasc Dis       Date:  2014-01-15

Review 5.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

Review 6.  Proteasomal and lysosomal protein degradation and heart disease.

Authors:  Xuejun Wang; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-11-14       Impact factor: 5.000

7.  Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency.

Authors:  Junping Hu; Janet D Klein; Jie Du; Xiaonan H Wang
Journal:  Endocrinology       Date:  2008-07-24       Impact factor: 4.736

8.  Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation.

Authors:  Ziyou Cui; Soyun Michelle Hwang; Aldrin V Gomes
Journal:  Mol Cell Biol       Date:  2013-10-28       Impact factor: 4.272

Review 9.  Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support.

Authors:  David A Liem; Ali Nsair; Shaun P Setty; Martin Cadeiras; Ding Wang; Robb Maclellan; Chris Lotz; Amanda J Lin; Jason Tabaraki; Hua Li; Junbo Ge; Jacob Odeberg; Fredrik Ponten; Erik Larson; Jan Mulder; Emma Lundberg; James N Weiss; Mathias Uhlen; Peipei Ping; Mario C Deng
Journal:  Circ Heart Fail       Date:  2014-03-01       Impact factor: 8.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.